Cargando…
Angiotensin (1−7) peptide replacement therapy with plasma transfusion in COVID-19
AIM: To determine whether convalescent angiotensin (1−7) peptide replacement therapy with plasma (peptide plasma) transfusion can be beneficial in the treatment of critically ill patients with severe coronavirus 2 (SARS-CoV-2) infection. STUDY DESIGN: Case series of 9 critically ill patients with la...
Autores principales: | Onal, Hasan, Ergun, Nurcan Ucuncu, Arslan, Bengu, Topuz, Seyma, Semerci, Seda Yilmaz, Ugurel, Osman Mutluhan, Topuzogullari, Murat, Kalkan, Ali, Yoldemir, Sengul Aydin, Suner, Nurettin, Kocatas, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917875/ https://www.ncbi.nlm.nih.gov/pubmed/35305923 http://dx.doi.org/10.1016/j.transci.2022.103418 |
Ejemplares similares
-
Treatment of COVID-19 patients with quercetin: a prospective, single center, randomized, controlled trial
por: ÖNAL, Hasan, et al.
Publicado: (2021) -
Delayed diagnosis of homocystinuria presenting with coronavirus disease 2019 in a 17-year-old boy
por: Yakut, Nurhayat, et al.
Publicado: (2022) -
An updated analysis of variations in SARS-CoV-2 genome
por: UGUREL, Osman Mutluhan, et al.
Publicado: (2020) -
Genomic chronicle of SARS-CoV-2: a mutational analysis with over 1 million genome sequences
por: UĞUREL, Osman Mutluhan, et al.
Publicado: (2021) -
Correlation of glycemic regulation and endotrophin in patients with type 2 Diabetes; pilot study
por: Yoldemir, Sengul Aydin, et al.
Publicado: (2021)